Two former executives of Taiwan-based JHL Biotech were indicted on charges of orchestrating the theft of trade secrets from Genentech. The U.S. government also charged the former chief executive officer and chief operating officer of that company with wire fraud and money laundering.
New York state filed civil charges accusing Johnson & Johnson of insurance fraud for downplaying the risks of opioid painkillers, including to doctors and elderly patients.
AbbVie Inc. agreed to pay $24 million to settle a lawsuit that alleged insurance fraud by the drugmaker in promoting the company’s blockbuster drug Humira, California’s insurance regulator said.
Medical diagnostic firm PerkinElmer Inc. faces a federal investigation into the company’s role in an alleged Medicare fraud involving tens of thousands of unnecessary genetic cancer tests, according to three sources with knowledge of the probe and documents reviewed by Reuters.
Frank Reynolds, the founder and former chief executive officer of PixarBio, was sentenced to seven years in prison for defrauding investors.
A federal judge dismissed some of the criminal charges Elizabeth Holmes is facing.
The Department of Justice leveled more charges against members of the U.S. science community who have alleged ties to China.
Federal authorities charged 10 former National Football League players for allegedly defrauding a healthcare program of more than $3.4 million by filing false claims for expensive medical equipment.
For Halloween, BioSpace collected six tales of thrills and chills from the pharma and biotech industries that will surely have you covering your eyes in terror.
One year after his arrest, PixarBio CEO Francis Reynolds was convicted of defrauding investors of $12.7 million.